1MUNGER K, BALDWIN A, EDWARDS K M. Mechanisms of human papillomavirus-induced oncogenesis [ J ]. J Virol, 2004,78(21) :11451 - 11460.
2ALI MAHDAVI, BRADLEY J, MONK. Vaccines Against human papillomavirus and cervical cancer: promises and challenges [ J ]. Oncologist,2005 (10) :528 - 538.
3KIVIAT, HAWES N B, FENG S E, Q H, et al. Screening for cervical cancer in the era of the HPV vaccine-The urgent need for both new screening guidelines and new biomarkers [ J ]. J Natl Cancer Inst, 2008,100 ( 5 ) : 308 - 309.
5KOHRMAN D C, SMITH M R, GOLDIN A L. A Missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting[ J]. Int J Neurosci, 1996,16(19) :5993 -5999.
6FRANCO E L, DUARTEFRANCO E, FERENCZY A. Cervical cancer: epidemiology,prevention and the role of human papillomavirus infection [ J]. CMAJ, 2001,164 (7) :1017 - 1025.
7BOURSNELL M E G, RUTHERFORD E, HICKLING J K, et al. Construction and characterization of a recombinant vaccinia virus epressing human papillomavirus proteins for immunotherapy of cervical cancer[ J]. Vaccine, 1996,14 (16) : 1485 - 1494.
8YUEN L, MOSS B. Oligonueleotide sequence signaling transcriptional termination of vaccinia virus early genes [J]. Proc Nail Acad Sci USA, 1987, 84(18): 6417 - 6421.
